Archives

by in
Entry Author Date Location
What Seattle Needs (Part 2): Dealing With Amgen’s Upcoming Departure 10/07/14 Seattle
Assigning Credit and Blame to Biopharma R&D Chiefs 05/29/13 Seattle
Roger Perlmutter Returns to Merck, Looks to Biotech Future (Again) 03/07/13 New York
Ironwood Bucks the Trends, Makes Big Bet on Drug For Millions 02/06/13 Boston
Xconomist of the Week: Roger Perlmutter’s Parting Thoughts on Amgen 03/01/12 National
Amgen CEO Kevin Sharer’s Report Card: C 12/19/11 National
Amgen Confirms 380 Layoffs in R&D; Cuts Coming to Seattle, SF, Boston 10/19/11 National
Amgen Looking to Improve Focus and “Re-allocate Resources” for R&D, Say More Oct. 24 10/12/11 National
Radius Raises $91 Million to Advance Osteoporosis Drug, Makes Strides Towards Public Listing 05/24/11 Boston
Amgen Passes Key Trial With “Son of Dmab” For Osteoporosis 04/21/11 National
Where Are Tomorrow’s Blockbuster Biotech Drugs Coming From? You Might be Surprised 03/14/11 National
Fluidigm Completes IPO on 2nd Try, Geron CEO Exits, Amgen Pushes ‘Son of Dmab,’ & More Bay Area Life Sciences News 02/11/11 San Francisco
Stromedix Adds Debt to Finance Clinical Trial, Eliza and Google Team Up for Health IT Website, Arsanis Gets $10M, & More Boston-Area Life Sciences News 02/11/11 Boston
Amgen Pushes Ahead With ‘Son of Dmab’ For Treating Broken, Frail Bones 02/09/11 National
Amgen’s R&D Chief, Roger Perlmutter, on Why BioVex’s Cancer-Fighting Virus Is Worth $1B 01/26/11 Boston
One Big Cancer Story from 2010, and Four Trends to Watch in 2011 01/14/11 San Francisco
Northern California’s Top 5 Biotech Innovation News Stories 12/28/10 San Francisco
Dendreon Commercial Guy Leaves, Light Sciences CEO Exits, Amgen Wins FDA OK, & More Seattle-Area Life Sciences News 11/24/10 Seattle
Amgen Wins FDA OK For Cancer Drug 11/18/10 Seattle
Amgen, Abbott Win BayBio Awards 11/05/10 San Francisco
Biotech Drug Discovery in Seattle: A Look Back 06/11/10 Seattle
Amgen Gets FDA Approval, SonoSite’s New Frontier, Craig Venter’s Enabler, & More Seattle-Area Life Sciences News 06/03/10 Seattle
Amgen’s Dmab Wins FDA Approval 06/01/10 Seattle
A Brief Year-End Review of Seattle Biotech 12/31/09 Seattle
Five Red Flags of a Biotech, Pathway Medical Learns Lessons, Amgen Faces FDA Delay, & More Seattle-Area Life Sciences News 10/22/09 Seattle
Amgen’s Dmab Faces FDA Delay 10/19/09 Seattle
Amgen’s Seattle and Boston Teams Seek to Boost Biotech Hit Rate 20 to 30 Percent 10/09/09 National
Amgen’s Dmab Works in Cancer Trial 07/07/09 Seattle
Amgen Shows Off Cancer Drug Pipeline Before Scientific Meeting 04/16/09 National
Amgen Cuts 100 Jobs in Bothell 04/09/09 Seattle
Page 1 of 2 next page »